CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-17 | LeBel Carl Chief Development Officer | Grant or award · Stock Option | +57,500 | 57,500 | ||
| 2022-08-17 | LeBel Carl Chief Development Officer | Returned to the company · Stock Option | −57,500 | 0 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Grant or award · Stock Option | +146,826 | 146,826 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Returned to the company · Stock Option | −146,826 | 0 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Grant or award · Stock Option | +57,500 | 57,500 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Returned to the company · Stock Option | −57,500 | 0 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Grant or award · Stock Option | +70,000 | 70,000 | ||
| 2022-08-17 | Loose Christopher R. Chief Scientific Officer | Returned to the company · Stock Option | −70,000 | 0 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Grant or award · Stock Option | +17,816 | 17,816 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Returned to the company · Stock Option | −17,816 | 0 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Grant or award · Stock Option | +18,000 | 18,000 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Returned to the company · Stock Option | −18,000 | 0 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Grant or award · Stock Option | +11,550 | 11,550 | ||
| 2022-08-17 | Mitrano Richard J. VP Finance & Operations | Returned to the company · Stock Option | −11,550 | 0 | ||
| 2022-08-17 | Arnold Wendy S Chief People Officer | Grant or award · Stock Option | +130,000 | 130,000 | ||
| 2022-08-17 | Arnold Wendy S Chief People Officer | Returned to the company · Stock Option | −130,000 | 0 | ||
| 2022-08-17 | Arnold Wendy S Chief People Officer | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2022-08-17 | Arnold Wendy S Chief People Officer | Returned to the company · Stock Option | −75,000 | 0 | ||
| 2022-08-17 | McCubbin Quentin Chief Manufacturing Officer | Grant or award · Stock Option | +90,000 | 90,000 | ||
| 2022-08-17 | McCubbin Quentin Chief Manufacturing Officer | Returned to the company · Stock Option | −90,000 | 0 |
Page 18 of 23 · 441 trades